| 2024-04-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP & Chief Accounting Officer | 240 <0.0001% | $419.00 | $100,560 | +4.86% | |
| 2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP & Chief Accounting Officer | 883 0.0003% | $425.70 | $375,893 | -3.7% | |
| 2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP & Chief Accounting Officer | 1,374 0.0005% | $420.24 | $577,410 | +0.03% | |
| 2023-05-30 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP & Chief Accounting Officer | 289 0.0001% | $329.82 | $95,318 | +14.05% | |
| 2023-02-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP & Chief Accounting Officer | 1,207 0.0005% | $287.55 | $347,072 | +21.88% | |
| 2022-04-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | SVP & Chief Accounting Officer | 83 <0.0001% | $269.51 | $22,369 | +7.68% |